作者: K Hansen , C Khanna
DOI: 10.1016/J.EJCA.2003.11.031
关键词: Genetically engineered 、 Drug 、 Cancer drugs 、 Genetically modified organism 、 Transplantation 、 Biology 、 Cancer 、 Transgene 、 Pharmacology 、 Bioinformatics 、 Pre-clinical development
摘要: The preclinical development of anticancer drugs has been based primarily on the transplantation of murine or human cancers into mice. Alternatives to these transplantation models are …